Kelly Conlon

579 total citations
20 papers, 424 citations indexed

About

Kelly Conlon is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Organic Chemistry. According to data from OpenAlex, Kelly Conlon has authored 20 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 3 papers in Organic Chemistry. Recurrent topics in Kelly Conlon's work include Heart Rate Variability and Autonomic Control (5 papers), Chemical Synthesis and Analysis (2 papers) and Nitric Oxide and Endothelin Effects (2 papers). Kelly Conlon is often cited by papers focused on Heart Rate Variability and Autonomic Control (5 papers), Chemical Synthesis and Analysis (2 papers) and Nitric Oxide and Endothelin Effects (2 papers). Kelly Conlon collaborates with scholars based in United Kingdom, United States and Belgium. Kelly Conlon's co-authors include C. Kidd, Cecil B. Kidd, Gordon McMurray, F. Markos, H. M. Snow, Gavin A. Whitlock, Alan Stobie, Lee R. Roberts, Matthew Skinner and Corina Dota and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Kelly Conlon

19 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly Conlon United Kingdom 12 153 105 89 63 52 20 424
N. Wesley Norton United States 9 58 0.4× 169 1.6× 62 0.7× 99 1.6× 19 0.4× 11 482
Ding Zhao China 15 79 0.5× 175 1.7× 43 0.5× 7 0.1× 45 0.9× 35 427
Angela Capriati Italy 10 88 0.6× 119 1.1× 62 0.7× 18 0.3× 12 0.2× 28 426
Maryam Shayan Iran 12 92 0.6× 122 1.2× 37 0.4× 6 0.1× 18 0.3× 38 466
Beatrice Riva Italy 12 87 0.6× 129 1.2× 65 0.7× 123 2.0× 4 0.1× 28 411
Hilary S. Eidam United States 10 21 0.1× 195 1.9× 83 0.9× 180 2.9× 20 0.4× 11 490
Selena Chen United States 16 190 1.2× 159 1.5× 120 1.3× 8 0.1× 52 1.0× 35 662
Herbert Barthlow United States 12 42 0.3× 183 1.7× 123 1.4× 11 0.2× 45 0.9× 15 402
Xiang Tian China 9 47 0.3× 100 1.0× 50 0.6× 7 0.1× 13 0.3× 38 328

Countries citing papers authored by Kelly Conlon

Since Specialization
Citations

This map shows the geographic impact of Kelly Conlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Conlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Conlon more than expected).

Fields of papers citing papers by Kelly Conlon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Conlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Conlon. The network helps show where Kelly Conlon may publish in the future.

Co-authorship network of co-authors of Kelly Conlon

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Conlon. A scholar is included among the top collaborators of Kelly Conlon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Conlon. Kelly Conlon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Robinson, Angela Byun, John Porter, Kelly Conlon, et al.. (2022). Targeting Ultrasmall Gold Nanoparticles with cRGD Peptide Increases the Uptake and Efficacy of Cytotoxic Payload. Nanomaterials. 12(22). 4013–4013. 8 indexed citations
2.
Porter, John, Yao Ding, Sarah Hale, et al.. (2020). A highly potent maytansinoid analogue and its use as a cytotoxic therapeutic agent in gold nanoparticles for the treatment of hepatocellular carcinoma. Bioorganic & Medicinal Chemistry Letters. 30(24). 127634–127634. 6 indexed citations
3.
Ashley, David M., et al.. (2020). TMOD-27. EFFICACY OF SOLUBLE PANOBINOSTAT (MTX110) IN PRECLINICAL MODELS OF ADULT GLIOBLASTOMA. Neuro-Oncology. 22(Supplement_2). ii233–ii233.
4.
Hale, Sarah, Ketan Patel, Angela Byun Robinson, et al.. (2018). DM1 Loaded Ultrasmall Gold Nanoparticles Display Significant Efficacy and Improved Tolerability in Murine Models of Hepatocellular Carcinoma. Bioconjugate Chemistry. 30(3). 703–713. 29 indexed citations
5.
Pollard, Christopher E., Matthew Skinner, Stanley E. Lazic, et al.. (2017). An Analysis of the Relationship Between Preclinical and Clinical QT Interval-Related Data. Toxicological Sciences. 159(1). 94–101. 42 indexed citations
6.
Conlon, Kelly, Joris H. De Maeyer, C. Bruce, et al.. (2017). Nonclinical Cardiovascular Studies of Prucalopride, a Highly Selective 5-Hydroxytryptamine 4 Receptor Agonist. Journal of Pharmacology and Experimental Therapeutics. 364(2). 156–169. 9 indexed citations
7.
Hider, Robert C., et al.. (2015). Deferitazole, a new orally active iron chelator. Dalton Transactions. 44(11). 5197–5204. 16 indexed citations
8.
Winchester, Wendy J., Sophie Glatt, Kelly Conlon, et al.. (2014). Inhibition of TRPM8 Channels Reduces Pain in the Cold Pressor Test in Humans. Journal of Pharmacology and Experimental Therapeutics. 351(2). 259–269. 72 indexed citations
9.
Hider, Robert C., et al.. (2013). SPD602 Is a Selective Iron Chelator Which Is Able To Mobilise The Non-Transferrin-Bound Iron Pool. Blood. 122(21). 1673–1673. 5 indexed citations
10.
Conlon, Kelly, et al.. (2011). Identification of 5‐HT 2C mediated mechanisms involved in urethral sphincter reflexes in a guinea‐pig model of urethral function. British Journal of Urology. 110(2b). E113–7. 5 indexed citations
11.
12.
Brennan, Paul E., et al.. (2009). Discovery of a novel azepine series of potent and selective 5-HT2C agonists as potential treatments for urinary incontinence. Bioorganic & Medicinal Chemistry Letters. 19(17). 4999–5003. 8 indexed citations
13.
Whitlock, Gavin A., Kelly Conlon, Gordon McMurray, et al.. (2008). Novel 2-imidazoles as potent and selective α1A adrenoceptor partial agonists. Bioorganic & Medicinal Chemistry Letters. 18(9). 2930–2934. 14 indexed citations
14.
Roberts, Lee R., Justin S. Bryans, Kelly Conlon, et al.. (2008). Novel 2-imidazoles as potent, selective and CNS penetrant α1A adrenoceptor partial agonists. Bioorganic & Medicinal Chemistry Letters. 18(24). 6437–6440. 18 indexed citations
15.
Markos, F., H. M. Snow, C. Kidd, & Kelly Conlon. (2002). Nitric Oxide Facilitates Vagal Control of Heart Rate Via Actions in the Cardiac Parasympathetic Ganglia of the Anaesthetised Dog. Experimental Physiology. 87(1). 49–52. 19 indexed citations
16.
Markos, F., H. M. Snow, C. Kidd, & Kelly Conlon. (2001). Inhibition of Neuronal Nitric Oxide Reduces Heart Rate Variability in the Anaesthetised Dog. Experimental Physiology. 86(5). 539–541. 14 indexed citations
17.
Conlon, Kelly & Cecil B. Kidd. (1999). Neuronal nitric oxide facilitates vagal chronotropic and dromotropic actions on the heart. Journal of the Autonomic Nervous System. 75(2-3). 136–146. 55 indexed citations
18.
Conlon, Kelly, et al.. (1998). The role of nitric oxide in the control by the vagal nerves of the heart of the ferret. Experimental Physiology. 83(4). 469–480. 25 indexed citations
19.
Conlon, Kelly, et al.. (1996). Modulation of vagal actions on heart rate produced by inhibition of nitric oxide synthase in the anaesthetized ferret. Experimental Physiology. 81(3). 547–550. 43 indexed citations
20.
Sznol, Mario, J. W. Clark, John W. Smith, et al.. (1992). Pilot Study of Interleukin-2 and Lymphokine-Activated Killer Cells Combined With Immunomodulatory Doses of Chemotherapy and Sequenced With Interferon Alfa-2a in Patients With Metastatic Melanoma and Renal Cell Carcinoma. JNCI Journal of the National Cancer Institute. 84(12). 929–937. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Wesley Norton Breakdown of academic impact, for papers by Ding Zhao Breakdown of academic impact, for papers by Angela Capriati Breakdown of academic impact, for papers by Maryam Shayan Breakdown of academic impact, for papers by Beatrice Riva Breakdown of academic impact, for papers by Hilary S. Eidam Breakdown of academic impact, for papers by Selena Chen Breakdown of academic impact, for papers by Herbert Barthlow Breakdown of academic impact, for papers by Xiang Tian
Rankless by CCL
2026